Latest Articles
Managing Progression After Immunotherapy in Endometrial Cancer - OncLive
Managing Progression After Immunotherapy in Endometrial Cancer OncLive
Published: May 5, 2026, 12:07 p.m.
High response rates in platinum-resistant ovarian cancer with immunotherapy agents - MSN
High response rates in platinum-resistant ovarian cancer with immunotherapy agents MSN
Published: April 20, 2026, 8:14 a.m.
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer - Pharmacy Times
Impact of Overall Survival Data on Immunotherapy Selection in Endometrial Cancer Pharmacy Times
Published: April 17, 2026, 12:30 p.m.
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents - MedPage Today
High Response Rates in Platinum-Resistant Ovarian Cancer With Immunotherapy Agents MedPage Today
Published: April 16, 2026, 7:11 p.m.
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma - Oncology Central
CAR-NKT cell therapy offers scalable, off-the-shelf immunotherapy for endometrial carcinoma Oncology Central
Published: March 23, 2026, 9:45 a.m.
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma - Oncology Central
CAR-NKT cell therapy: a scalable immunotherapy option for endometrial carcinoma Oncology Central
Published: March 23, 2026, 9:45 a.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - Cure Today
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models Cure Today
Published: March 17, 2026, 5:11 p.m.
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - CUREtoday.com
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models CUREtoday.com
Published: March 17, 2026, 4:12 p.m.
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors - Technology Networks
CAR-NKT Immunotherapy Shows Preclinical Success Against Endometrial Tumors Technology Networks
Published: March 17, 2026, 4:04 p.m.
UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer - Sierra Sun Times
UCLA Researchers Say Universal, Ready-To-Use Immunotherapy Detects and Destroys Endometrial Cancer Sierra Sun Times
Published: March 17, 2026, 2:29 p.m.
Link copied to clipboard!